Johnson & Johnson CONTACT LENSES / OTHER — Sales to customers (Note 9) decreased by 3.9% to $969.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.4%, from $919.00M to $969.00M. Over 4 years (FY 2021 to FY 2025), CONTACT LENSES / OTHER — Sales to customers (Note 9) shows an upward trend with a 3.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growing market share or higher consumer demand for vision care products, while a decrease may signal increased competition or a shift in consumer preferences.
This metric represents the total net revenue generated from the sale of contact lenses and associated vision care produc...
Comparable to revenue reported by other medical device or consumer health companies with dedicated vision care or optical business units.
jnj_segment_contact_lenses_other_sales_to_customers_note_9| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $868.00M | $882.00M | $833.00M | $910.00M | $894.00M | $908.00M | $831.00M | $953.00M | $939.00M | $928.00M | $882.00M | $910.00M | $918.00M | $968.00M | $937.00M | $919.00M | $965.00M | $1.02B | $1.01B | $969.00M |
| QoQ Change | — | +1.6% | -5.6% | +9.2% | -1.8% | +1.6% | -8.5% | +14.7% | -1.5% | -1.2% | -5.0% | +3.2% | +0.9% | +5.4% | -3.2% | -1.9% | +5.0% | +5.5% | -1.0% | -3.9% |
| YoY Change | — | — | — | — | +3.0% | +2.9% | -0.2% | +4.7% | +5.0% | +2.2% | +6.1% | -4.5% | -2.2% | +4.3% | +6.2% | +1.0% | +5.1% | +5.2% | +7.6% | +5.4% |